Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00477867 | Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172 | withdrawn | N/A | 0 | Gynecologic Oncology GroupNETWORK | 0 | Jun 10, 2013 | clinicaltrials |
| NCT01238146 | Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma | withdrawn | Phase 1 / Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 |
| clinicaltrials |
| NCT01293942 | IXO+A in mCRC With Liver-only Metastases | withdrawn | Phase 2 | 0 | Ottawa Hospital Research InstituteOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00238160 | Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer | withdrawn | Phase 3 | 0 | Kyoto UniversityOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00954837 | Assessment of Repeat Fine Needle Aspiration (FNA) to Detect Thyroid Cancer(CYT2THYR) | withdrawn | N/A | 0 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | May 27, 2013 | clinicaltrials |
| NCT01733836 | Prostate Cancer Active Surveillance Metformin Trial | withdrawn | Phase 2 | 0 | University Health Network, TorontoOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT01013506 | Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer | withdrawn | Phase 2 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | May 23, 2013 | clinicaltrials |
| NCT01141868 | Evaluating an Internet-based Intervention for Insomnia in Breast Cancer Survivors | withdrawn | N/A | 0 | Milton S. Hershey Medical CenterOTHER | 0 | May 17, 2013 | clinicaltrials |
| NCT01219907 | Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer | withdrawn | Phase 1 | 0 | University of WashingtonOTHER | 1 | May 17, 2013 | clinicaltrials |
| NCT01736878 | Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma(SUMMIT) | withdrawn | Phase 2 | 0 | Eanm Research LtdNETWORK | 1 | May 17, 2013 | clinicaltrials |
| NCT01707758 | Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence | withdrawn | — | 0 | University of KansasOTHER | 0 | May 16, 2013 | clinicaltrials |
| NCT00357461 | Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma | withdrawn | Phase 2 | 0 | Bristol-Myers SquibbINDUSTRY | 0 | May 15, 2013 | clinicaltrials |
| NCT00801918 | Denileukine Diftitox for Relapsed ALCL | withdrawn | Phase 2 | 0 | Columbia UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT01674374 | Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | May 15, 2013 | clinicaltrials |
| NCT00447356 | High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma | withdrawn | Phase 3 | 0 | Hackensack Meridian HealthOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT00055887 | Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer | withdrawn | Phase 3 | 0 | Spectrum Pharmaceuticals, IncINDUSTRY | 4 | May 10, 2013 | clinicaltrials |
| NCT00916669 | A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) | withdrawn | Phase 2 | 0 | Massachusetts General HospitalOTHER | 1 | May 8, 2013 | clinicaltrials |
| NCT00606970 | Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy | withdrawn | Early Phase 1 | 0 | New Hope Medical CenterNETWORK | 0 | May 7, 2013 | clinicaltrials |
| NCT00043212 | Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. | withdrawn | Phase 3 | 0 | Northwest BiotherapeuticsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT01781442 | A Post Marketing Surveillance As Required By Philippine Food And Drug Administration | withdrawn | — | 0 | PfizerINDUSTRY | 0 | May 1, 2013 | clinicaltrials |
| NCT00577980 | Testosterone in Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 29, 2013 | clinicaltrials |
| NCT00903214 | Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer | withdrawn | Phase 1 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 29, 2013 | clinicaltrials |
| NCT00691977 | Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate | withdrawn | Phase 1 | 0 | Virginia Commonwealth UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00268255 | Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 16, 2013 | clinicaltrials |
| NCT00960427 | Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | withdrawn | Phase 1 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 16, 2013 | clinicaltrials |
| NCT00968461 | Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 15, 2013 | clinicaltrials |
| NCT00873808 | S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307 | withdrawn | — | 0 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00899002 | Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer | withdrawn | — | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 10, 2013 | clinicaltrials |
| NCT01432119 | Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 9, 2013 | clinicaltrials |
| NCT00258466 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | withdrawn | Phase 3 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 8, 2013 | clinicaltrials |
| NCT01616186 | Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) | withdrawn | Phase 2 | 0 | Andrea HarzstarkOTHER | 0 | Apr 8, 2013 | clinicaltrials |
| NCT00968396 | Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT01340729 | Open-Label Study of TPI 287 for Patients With Metastatic Melanoma | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01427205 | Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT01508260 | Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT00253617 | Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 2 | Apr 4, 2013 | clinicaltrials |
| NCT00499668 | Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer | withdrawn | N/A | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT00601991 | A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia | withdrawn | Phase 2 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT01480141 | A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC) | withdrawn | Phase 2 | 0 | Medical University of South CarolinaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00025051 | Celecoxib in Preventing Skin Cancer | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00030355 | Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia | withdrawn | Phase 1 / Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Mar 22, 2013 | clinicaltrials |
| NCT01786538 | Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines | withdrawn | Phase 3 | 0 | Asan Medical CenterOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00003435 | Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer | withdrawn | Phase 1 | 0 | Duke UniversityOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT01416844 | Study of Immune Responses in Patients With Metastatic Melanoma | withdrawn | Phase 2 | 0 | Providence Health & ServicesOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT01478308 | Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | New Mexico Cancer Research AllianceOTHER | 0 | Mar 6, 2013 | clinicaltrials |
| NCT00601120 | RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma | withdrawn | N/A | 0 | Beth Israel Deaconess Medical CenterOTHER | 1 | Feb 27, 2013 | clinicaltrials |
| NCT01401387 | Pancreatic Enzyme Suppletion in Pancreatic Cancer(EPC) | withdrawn | Phase 4 | 0 | Foundation for Liver ResearchOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00311545 | S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Feb 20, 2013 | clinicaltrials |
| NCT01680796 | Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma | withdrawn | Phase 1 | 0 | University of FloridaOTHER | 0 | Feb 20, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jun 10, 2013source: clinicaltrials